Onconetix, Inc.

Onconetix, Inc. (ticker: ONCO) is an NASDAQ-listed pharmaceutical preparations company. DredgeCap's structured extraction of ONCO's SEC filings surfaces 9 active risk signals, including 7 late-filing signals, and 2 auditor-change signals. ONCO reported $21K in revenue and -$4.21M for the period ending 2026-03-31, with operating cash flow of -$2.12M. Cash and equivalents stood at $3.72M (up 135.6% year-over-year). Total assets of $14.83M exceed total liabilities of $3.08M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.